Oruka Therapeutics, Inc. ORKA Increase (decrease) in amount of unrecognized tax benefits

Increase (decrease) in amount of unrecognized tax benefits at other companies

Oruka Therapeutics, Inc.ORKA

$22.75K—

Equitable HoldingsEQH

$3.25M+117%

Ollie's Bargain Outlet Holdings, Inc.OLLI

$0—

Vertex PharmaceuticalsVRTX

$36.48M+61.6%

F5, Inc.FFIV

$225K-83.9%

International Business MachinesIBM

-$555M-2,255%

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s increase (decrease) in amount of unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s increase (decrease) in amount of unrecognized tax benefits?: Oruka Therapeutics, Inc. (ORKA) reported increase (decrease) in amount of unrecognized tax benefits of $22.75K in Q4 2025.
What does increase (decrease) in amount of unrecognized tax benefits mean?: This reflects the net change in the reserve for uncertain tax positions during the reporting period. It provides insight into the company's tax risk profile and the potential volatility of future tax liabilities.